Login Register Cart 0
Generic placeholder image

Drug Delivery Letters

Editor-in-Chief

ISSN (Print): 2210-3031
ISSN (Online): 2210-304X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Development of Mucoadhesive Buccal Drug Delivery System of Propranolol Hydrochloride Using Aster ericoides Mucilage

Author(s): Ankaj Kaundal, Pravin Kumar, Rajendra Awasthi and Giriraj T. Kulkarni*

Volume 10, Issue 2, 2020

Page: [133 - 148] Pages: 16

DOI: 10.2174/2210303109666191010164201

Price: $65

Abstract

Aims: The study was aimed to develop mucoadhesive buccal tablets using Aster ericoides leaves mucilage.

Background: Mucilages are naturally occurring high-molecular-weight polyuronides, which have been extensively studied for their application in different pharmaceutical dosage forms.

Objective: The objective of the present research was to establish the mucilage isolated from the leaves of Aster ericoides as an excipient for the formulation of the mucoadhesive buccal tablet.

Methods: The mucilage was isolated from the leaves of Aster ericoides by maceration, precipitated with acetone and characterized. Tablets were prepared using wet granulation technique and evaluated for various official tests.

Results: The mucilage was found to be non-toxic on A-431 and Vero cell lines. It was insoluble but swellable in cold and hot water. The results indicate that mucilage can form a three-dimensional network. The pH of the mucilage (6.82 ± 0.13) indicated that it might be non-irritant to the buccal cavity. The mucilage was found to be free from microbes. The release of drug was by Fickian diffusion. The in vivo buccal tablet acceptance was 80%. No significant difference between the diastolic blood pressure of standard and Aster tablets treated volunteer group was recorded.

Conclusion: It might be concluded that the isolated mucilage from the leaves of Aster ericoides may be used as an excipient for the development of mucoadhesive buccal tablets.

Other: However, to prove the potency of the polymer, in vivo bioavailability studies in human volunteers are needed along with chronic toxicity studies in suitable animal models.

Keywords: Bioadhesion, mucoadhesion, mucilage, extract, natural polymer, buccal tablet.

« Previous Next »
Graphical Abstract

[1]
Asane, G.S.; Nirmal, S.A.; Rasal, K.B.; Naik, A.A.; Mahadik, M.S.; Rao, Y.M. Polymers for mucoadhesive drug delivery system: a current status. Drug Dev. Ind. Pharm., 2008, 34(11), 1246-1266.
[http://dx.doi.org/10.1080/03639040802026012] [PMID: 18720139]
[2]
Gremiao, M.P.D.; Carvalho, F.C.; Bruschi, M.L.; Evangelisla, R.C. Mucoadhesive drug delivery system. Braz. J. Pharm. Sci., 2010, 46(1), 1-17.
[http://dx.doi.org/10.1590/S1984-82502010000100002]
[3]
Tangri, P.; Madhav, N.V.S. Oral mucoadhesive drug delivery system. International Journal of Biopharmaceutics, 2011, 2(1), 36-46.
[4]
Smart, J.D. The basics and underlying mechanisms of mucoadhesion. Adv. Drug Deliv. Rev., 2005, 57(11), 1556-1568.
[http://dx.doi.org/10.1016/j.addr.2005.07.001] [PMID: 16198441]
[5]
Boddupalli, B.M.; Mohammed, Z.N.; Nath, R.A.; Banji, D. Mucoadhesive drug delivery system: An overview. J. Adv. Pharm. Technol. Res., 2010, 1(4), 381-387.
[http://dx.doi.org/10.4103/0110-5558.76436] [PMID: 22247877]
[6]
Kaur, G.; Rana, V. Chitosan: Modifications and Applications in Dosage Form Design.Chitosan: Manufacture, properties and usage; Davis, S.P., Ed.; Nova Science Publishers: New York, NY, USA, 2011, pp. 71-132.
[7]
Shaikh, R.; Raj Singh, T.R.; Garland, M.J.; Woolfson, A.D.; Donnelly, R.F. Mucoadhesive drug delivery systems. J. Pharm. Bioallied Sci., 2011, 3(1), 89-100.
[http://dx.doi.org/10.4103/0975-7406.76478] [PMID: 21430958]
[8]
Prajapati, V.D.; Jani, G.K.; Moradiya, N.G.; Randeria, N.P. Pharmaceutical applications of various natural gums, mucilages and their modified forms. Carbohydr. Polym., 2013, 92(2), 1685-1699.
[http://dx.doi.org/10.1016/j.carbpol.2012.11.021] [PMID: 23399207]
[9]
Kulkarni, G.T. Process of development of excipients from natural sources. Indian J. Pharm., 2010, 1(1), 1-7.
[10]
Malviya, R.; Srivastava, P.; Kulkarni, G.T. Applications of mucilages in drug delivery. Adv. Biol. Res. (Faisalabad), 2011, 5(1), 1-7.
[11]
Shanmugam, S.; Manavalan, R.; Venkappayya, V.; Sundramoorthy, K. Natural polymers and their applications. Nat. Prod. Rad., 2004, 4(6), 478-481.
[12]
Alexander, A.; Ajazuddin, M.; Swarna, M.; Sharma, M.; Tripathi, D.K. Polymers and permeation enhancers: Specialized components of mucoadhesives. Stamford. J. Pharm. Sci., 2011, 4(1), 91-95.
[13]
Tripathi, K.D. Essentials of medical pharmacology; 4th ed.; Jaypee Brothers Medical Publishers (P) Ltd.: New Delhi, 2008.
[http://dx.doi.org/10.5005/jp/books/10282]
[14]
Denizot, F.; Lang, R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods, 1986, 89(2), 271-277.
[http://dx.doi.org/10.1016/0022-1759(86)90368-6] [PMID: 3486233]
[15]
Khandelwal, K.R. Practical pharmacognosy - Techniques and Experiments: Preliminary Phytochemical Screening, 19th ed; Nirali Prakashan, 2008.
[16]
Chaudhary, A.; Kulkarni, G.T.; Awasthi, R.; Kumar, P. Investigation on binding properties of Grewia asiatica mucilage in tablet formulations. Marmara Pharm. J., 2016, 20, 353-367.
[http://dx.doi.org/10.12991/mpj.20162032588]
[17]
Kumar, P.; Kulkarni, G.T. Characterization of mucilage from Grewia optiva as pharmaceutical excipient. Journal of Chronotherapy and Drug Delivery, 2012, 3(2), 55-67.
[18]
Martin, A.; Swarbrick, J.; Cammarata, A. Physical Pharmacy, 3rd ed; Varghese Publishing House: Mumbai, 1991.
[19]
Mathiowitz, E. Chickering DE III, Lehr CM. Bioadhesive Drug Delivery Systems, Fundamentals, Novel Approaches, and Development; Marcel Dekker, Inc.: New York, 2010.
[20]
Phanikumar, G.K.; Battu, G.; Lova Raju, N.S. Isolation and evaluation of tamarind seed polysaccharide being used as polymer in pharmaceutical dosage form. Res. J. Pharm. Biol. Chem. Sci., 2011, 2(2), 274-290.
[21]
Patel, V.M.; Prajapati, B.G.; Patel, M.M. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech, 2007, 8(1), E1-E8.
[http://dx.doi.org/10.1208/pt0801022]
[22]
Busst, C.M.; Bush, A. Comparison of the cardiovascular and pulmonary effects of oral celiprolol, propranolol and placebo in normal volunteers. Br. J. Clin. Pharmacol., 1989, 27(4), 405-410.
[http://dx.doi.org/10.1111/j.1365-2125.1989.tb05386.x] [PMID: 2566321]
[23]
de Rover, M.; van Noorden, M.S.; Nieuwenhuis, S.; van der Wee, N.J.A. Cardiorespiratory arrest in a healthy volunteer after a single oral dose of 80 mg of the beta-blocker propranolol. Neurobiol. Learn. Mem., 2010, 94(4), 576-577.
[http://dx.doi.org/10.1016/j.nlm.2010.09.002] [PMID: 20828628]
[24]
Kulkarni, G.T. Pharmaceutical and biotechnological applications of natural hydrogels; VDM–Verlag Dr. Muller GmbH & Co: Saarbrucken, Germany, 2010.
[25]
Steiner, J.A.; Clancy, A.; Manghani, K.K.; James, I.M. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers. Br. J. Clin. Pharmacol., 1981, 12(4), 573-578.
[http://dx.doi.org/10.1111/j.1365-2125.1981.tb01267.x] [PMID: 6117309]
[26]
Pavia, D.L.; Lampman, G.M.; Kriz, G.S.; Vyvyan, J.R. Spectroscopy, 9th ed; Cengage Learning: New Delhi, 2011, pp. 26-92.
[27]
Awasthi, R.; Kulkarni, G.T. Development of novel gastroretentive drug delivery system of gliclazide: hollow beads. Drug Dev. Ind. Pharm., 2014, 40(3), 398-408.
[http://dx.doi.org/10.3109/03639045.2013.763817] [PMID: 23418961]
[28]
Kulkarni, G.T.; Seshubabu, P.; Kumar, S.M. Effect of tamarind seed polysaccharide on dissolution behaviour of ibuprofen tablets. Journal of Chronotherapy and Drug Delivery, 2011, 2(1), 49-56.
[29]
Builders, P.F.; Ogwuche, P.; Isimi, Y.; Kunle, O.O. Some critical effects of starch gel on the granule and tablet properties of a potent herbal extract AM-1. Afr. J. Pharm. Pharmacol., 2011, 5(13), 1603-1611.
[http://dx.doi.org/10.5897/AJPP10.357]
[30]
Aklilu, T. Evaluation of local gum of Acacia polyacanthaas a binder in tablet formulations [Dissertation]; School of Graduate studies: Addis Ababa University, 2002.
[31]
Well, J. Pharmaceutical preformulation.Aulton, M.E., Ed.;The science of dosage form design; 2nd ed; Churchill Livingstone: Toronto, 2003. pp. 113-138
[32]
Junginger, H.E.; Verhoef, J.C.; Thanou, M. Drug delivery-mucoadhesive hydrogels.Encyclopedia of pharmaceutical technology; Swarbrick, J., Ed.; Informa Healthcare: New York, 2007, Vol. 2, p. 1169.
[33]
Venkatesh, D.P.; Rao, C.G.G. Formulation of taste masked oro-dispersible tablets of ambroxol hydrochloride. Asian J. Pharm, 2008, 2(4), 261-264.
[http://dx.doi.org/10.4103/0973-8398.45043]
[34]
Siepmann, J.; Peppas, N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev., 2001, 48(2-3), 139-157.
[http://dx.doi.org/10.1016/S0169-409X(01)00112-0] [PMID: 11369079]
[35]
Ritger, P.L.; Peppas, N.A. A Simple Equation for Description of Solute Release I. Fickian and non-Fickian Release from non-Swellable Devices in the Form of Slabs, Spheres, Cylinders or Discs. J. Control. Release, 1987, 5, 23-36.
[http://dx.doi.org/10.1016/0168-3659(87)90034-4]
[36]
Ritger, P.L.; Peppas, N.A. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Release, 1987, 5, 37-42.
[http://dx.doi.org/10.1016/0168-3659(87)90035-6]
[37]
Bolton, S.; Bon, C. Pharmaceutical Statistics Practical and Clinical Applications, 5th ed; Informa HealthCare: Newyork, 2010, p. 1.

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy